SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Michael Anthony who wrote (213)1/9/1998 7:15:00 PM
From: Steve Johnston  Read Replies (1) | Respond to of 1321
 
Looking at the trading summary, it appeared to have been halted prior to the market closing. News release itself came out at 4:01 PM. By the way I totally agree with your opinions on ARMD. Regards.



To: Michael Anthony who wrote (213)1/9/1998 8:42:00 PM
From: Ian@SI  Read Replies (1) | Respond to of 1321
 
Michael,

Do you know the breakdown of the wet form vs the dry form of ARMD?
I believe the treatment is only applicable for the wet form which is less prevalent.

Ian.



To: Michael Anthony who wrote (213)1/14/1998 8:01:00 AM
From: Raymond McIsaac  Read Replies (1) | Respond to of 1321
 
Hi:

What do you think (all posters) of the connection between this treatment and the Xillix (XLX) technology for early detection of lung cancer and soon gastro-intestinal and cervical cancers.

the reason i pose this is that Xillix IR has said in the past good news for QLT is good news for us. The connection seems obviouse two world leading technologies..one aimed at detection the other treatment. Both unrivaled or so we are to assume.

R


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News